Natsar Pharmaceuticals, Inc.
Ellicott City, MD
- UEI
- F2KMK7BBBMS3
- CAGE
- 7SYA4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4624 Tall Maple Ct, Ellicott City, MD 21043, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Drug development of RK-33 for breast cancer treatment - triple-negative breast cancers (tnbcs) are breast cancers that… | National Cancer Institute | $1,634,811 |
Quick answers
What is Natsar Pharmaceuticals, Inc.'s UEI?
Natsar Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is F2KMK7BBBMS3.
What is Natsar Pharmaceuticals, Inc.'s CAGE code?
Natsar Pharmaceuticals, Inc.'s CAGE code is 7SYA4.
Where is Natsar Pharmaceuticals, Inc. located?
Natsar Pharmaceuticals, Inc.'s physical address in SAM.gov is 4624 Tall Maple Ct, Ellicott City, MD 21043, USA.
Is Natsar Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Natsar Pharmaceuticals, Inc.'s SAM.gov registration is active through March 4, 2027.
What is Natsar Pharmaceuticals, Inc.'s most recent federal award?
Natsar Pharmaceuticals, Inc.'s most recent federal grant award is Drug development of RK-33 for breast cancer treatment - triple-negative breast cancers (tnbcs) are breast cancers that… (R44CA295155), from National Cancer Institute, on September 22, 2025.
On GovTribe
See Natsar Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors